[HTML][HTML] Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in …

O Dereure, E Levi, ME Kadin, EC Vonderheid - Journal of investigative …, 2002 - Elsevier
Mycosis fungoides (MF) is the most frequent manifestation of cutaneous T cell lymphoma but
its cause and pathophysiology remain unclear. Because progression of lesions is …

Fas Gene Mutations in Mycosis fungoides: Analysis of Laser Capture-Microdissected Specimens from Cutaneous Lesions

T Nagasawa, T Takakuwa, H Takayama, Z Dong… - Oncology, 2004 - karger.com
Abstract Fas (APO-1/CD95) is a transmembrane protein which mediates programmed cell
death (apoptosis). Cells with a mutated Fas gene are resistant to apoptosis and thus …

The Fas apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis

N Stutz, RD Johnson, GS Wood - Journal of the American Academy of …, 2012 - Elsevier
Background Low proliferation rates, sparse apoptotic cells, and resistance to
chemotherapeutic agents suggest that defective apoptotic mechanisms may be important in …

Reversible resistance to apoptosis in cutaneous T cell lymphoma

SJ Meech, R Edelson, P Walsh… - Annals of the New …, 2001 - Wiley Online Library
Mycosis fungoides and its leukemic variant, Sézary syndrome, represent the most common
forms of cutaneous T cell lymphomas (CTCL). These disorders are clonal neoplasms …

A Novel Splice Variant of the Fas Gene in Patients with Cutaneous T-Cell Lymphoma

R van Doorn, R Dijkman, MH Vermeer, TM Starink… - Cancer research, 2002 - AACR
Defective apoptosis signaling has been implicated in the pathogenesis of primary cutaneous
T-cell lymphomas (CTCLs), a group of malignancies derived from skin-homing T cells. An …

[HTML][HTML] Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation

J Wu, M Nihal, J Siddiqui, EC Vonderheid… - Journal of investigative …, 2009 - Elsevier
FAS expression was generally low in 30 of 31 cutaneous T-cell lymphoma (CTCL) cases
(mycosis fungoides/Sezary syndrome, SS) as well as in 5 of 6 large plaque parapsoriasis …

Expression of Fas and Fas‐ligand in primary cutaneous T‐cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL

O Zoi‐Toli, MH Vermeer, E De Vries… - British Journal of …, 2000 - academic.oup.com
Abstract Background Fas (CD95; APO‐1) is a transmembrane protein that mediates
apoptosis upon cross‐linking with Fas‐ligand (Fas‐L). Interaction of Fas‐L expressed by …

Decreased expression of Fas (APO‐1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T‐cell lymphomas

O Dereure, P Portales, J Clot… - British Journal of …, 2000 - academic.oup.com
Background The usually protracted and indolent course of cutaneous T‐cell lymphoma
(CTCL) is consistent with an accumulation of lymphocytes rather than being a true …

Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL)

J Wu, J Siddiqui, M Nihal, EC Vonderheid… - Archives of biochemistry …, 2011 - Elsevier
FAS (TNF receptor superfamily member 6, also known as CD95) plays a major role in T-cell
apoptosis and is often dysregulated in CTCL. We searched for structural alterations of the …

[HTML][HTML] Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression

G Li, L Chooback, JT Wolfe, AH Rook, CA Felix… - Journal of investigative …, 1998 - Elsevier
The molecular mechanisms by which advanced cases of cutaneous T cell lymphoma
(CTCL)(mycosis fungoides/Sezary syndrome) undergo large cell transformation (LCT) and …